HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration

Yu Sun; Xiujuan Wei; Fang Fang; Yiping Shen; Haiyan Wei; Jiuwei Li; Xianglai Ye; Yongkun Zhan; Xiantao Ye; Xiaomin Liu; Wei Yang; Yuhua Li; Xiangju Geng; Xuelin Huang; Yiyan Ruan; Zailong Qin; Shang Yi; Jianxin Lyu; Hezhi Fang; Yongguo Yu

doi:10.1016/j.jgg.2021.01.009

Volume 48 Issue 8

Aug. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2021 > 48(8): 727-736

PDF( 1325 KB)

HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration

doi: 10.1016/j.jgg.2021.01.009

a Department of Pediatric Endocrinology and Genetics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute for Pediatric Research, Shanghai 200092, China;
b Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China;
c Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
d The Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Guangxi Birth Defects Prevention and Control Institute, Nanning 530000, China;
e Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China;
f Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA;
g Department of Endocrinologic and Inherited Metabolic, Henan Childen's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450018, China;
h Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;
i Department of Rehabilitation, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450018, China;
j Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou 310014, China;
k Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai 200092, China

Funds:

We thank the patients and their family members for their participation. The patient’s lymphoblastoid cell line was generated by Mengni Yi (Xinhua Hospital, Shanghai Jiaotong University School of Medicine). The skin biopsy was performed under the supervision of Dr. Ming Li (Xinhua Hospital, Shanghai Jiaotong University School of Medicine). The Shanghai Clinical Research Center provided the computation cluster to analyze the genome sequencing data. This work was funded by the Precision Medical Research of National Key Research and Development Program (2018YFC1002200, 2019YFC1005100 to Y. Yu, 2018YFC1002400 to Y. Sun, and 2018YFC1002501 to Y. Shen), National Natural Science Foundation of China (81873633 and 82071276 to Y. Shen, 81830071 to J. Lyu, 81873724 to Y. Sun, and 82070914 and 81873671 to Y. Yu), Shanghai Shen Kang Hospital Development Center (SHDC12017109 to Y. Yu), the Shanghai Science and Technology Commission (19140904500 to Y. Yu), Jiaotong University Cross Biomedical Engineering (YG2017MS72 to Y. Yu), the “Eastern Scholar” Fund, the “Guangxi Bagui Scholar” fund (to Y. Shen), the Major Research Plan of the Provincial Science and Technology Foundation of Guangxi (AB16380214 to Y. Shen) and Foundation of Shanghai Municipal Health Commission (shslczdzk05702, to Y. Yu and Y. Sun), and Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20191908, to Y. Yu).

Received Date: 2020-11-18
Accepted Date: 2021-01-17
Rev Recd Date: 2021-01-11
Publish Date: 2021-08-20

Abstract

Abstract

Mitochondrial diseases are caused by variants in both mitochondrial and nuclear genomes. A nuclear gene HPDL (4-hydroxyphenylpyruvate dioxygenase-like), which encodes an intermembrane mitochondrial protein, has been recently implicated in causing a neurodegenerative disease characterized by pediatric-onset spastic movement phenotypes. Here, we report six Chinese patients with bi-allelic HPDL pathogenic variants from four unrelated families showing neuropathic symptoms of variable severity, including developmental delay/intellectual disability, spasm, and hypertonia. Seven different pathogenic variants are identified, of which five are novel. Both fibroblasts and immortalized lymphocytes derived from patients show impaired mitochondrial respiratory function, which is also observed in HPDL-knockdown (KD) HeLa cells. In these HeLa cells, overexpression of a wild-type HPDL gene can rescue the respiratory phenotype of oxygen consumption rate. In addition, a decreased activity of the oxidative phosphorylation (OXPHOS) complex Ⅱ is observed in patient-derived lymphocytes and HPDL-KD HeLa cells, further supporting an essential role of HPDL in the mitochondrial respiratory chain. Collectively, our data expand the clinical and mutational spectra of this mitochondrial neuropathy and further delineate the possible disease mechanism involving the impairment of the OXPHOS complex Ⅱ activity due to the bi-allelic inactivations of HPDL.
- HPDL gene,
- Mitochondrial disease,
- Respiration impairment,
- OXPHOS,
- Respiration chain complex II

Yongguo Yu, Hezhi Fang and Jianxin Lyu jointly directed this work as corresponding authors.

FullText(HTML)

References(36)

References

Ahmad, M., Wolberg, A., Kahwaji, C.I., 2021. Biochemistry, electron transport chain. Statpearls, Treasure Island (FL).

Badugu, R., Garcia, M., Bondada, V., Joshi, A., Geddes, J.W., 2008. N terminus of calpain 1 is a mitochondrial targeting sequence. J. Biol. Chem. 283, 3409-3417.

Birch-Machin, M.A., Turnbull, D.M., 2001. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 65, 97-117.

Chen, G., Guo, G., Zhou, X., Chen, H., 2020. Potential mechanism of ferroptosis in pancreatic cancer. Oncol. Lett. 19, 579-587.

Craven, L., Alston, C.L., Taylor, R.W., Turnbull, D.M., 2017. Recent advances in mitochondrial disease. Annu. Rev. Genom. Hum. Genet. 18, 257-275.

DiMauro, S., 2004. Mitochondrial diseases. Biochim. Biophys. Acta 1658, 80-88.

Faiyaz-Ul-Haque, M., Zaidi, S.H., Hasanato, R.M., Al-Abdullatif, A., Cluntun, A., Teresita, G., Toulimat, M., Al-Nounou, R., Al-Dayel, F., Peltekova, I., 2010. Genetics of glucose-6-phosphate dehydrogenase deficiency in saudi patients. Clin. Genet. 78, 98-100.

Frazier, A.E., Thorburn, D.R., Compton, A.G., 2019. Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology. J. Biol. Chem. 294, 5386-5395.

Frezza, C., Cipolat, S., Scorrano, L., 2007. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2, 287-295.

Gao, M., Monian, P., Quadri, N., Ramasamy, R., Jiang, X., 2015. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell. 59, 298-308.

Gorman, G.S., Chinnery, P.F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D.R., Zeviani, M., Turnbull, D.M., 2016. Mitochondrial diseases. Nat. Rev. Dis. Primers 2, 16080.

Gorman, G.S., Schaefer, A.M., Ng, Y., Gomez, N., Blakely, E.L., Alston, C.L., Feeney, C., Horvath, R., Yu-Wai-Man, P., Chinnery, P.F., 2015. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann. Neurol. 77, 753-759.

Griswold, A.J., Ma, D., Cukier, H.N., Nations, L.D., Schmidt, M.A., Chung, R.H., Jaworski, J.M., Salyakina, D., Konidari, I., Whitehead, P.L., 2012. Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Hum. Mol. Genet. 21, 3513-3523.

Grzybowska, E.A., 2012. Human intronless genes: functional groups, associated diseases, evolution, and mRNA processing in absence of splicing. Biochem. Biophys. Res. Commun. 424, 1-6.

Gusic, M., Prokisch, H., 2021. Genetic basis of mitochondrial diseases. FEBS Lett. 595, 1132-1158.

Husain, R.A., Grimmel, M., Wagner, M., Hennings, J.C., Marx, C., Feichtinger, R.G., Saadi, A., Rostasy, K., Radelfahr, F., Bevot, A., 2020. Bi-allelic HPDL variants cause a neurodegenerative disease ranging from neonatal encephalopathy to adolescent-onset spastic paraplegia. Am. J. Hum. Genet. 107, 364-373.

Iwanicka-Pronicka, K., Ciara, E., Piekutowska-Abramczuk, D., Halat, P., Pajdowska, M., Pronicki, M., 2019. Congenital cochlear deafness in mitochondrial diseases related to RRM2B and SERAC1 gene defects. A study of the mitochondrial patients of the CMHI hospital in Warsaw, Poland. Int. J. Pediatr. Otorhinolaryngol. 121, 143-149.

Jain-Ghai, S., Cameron, J.M., Al Maawali, A., Blaser, S., MacKay, N., Robinson, B., Raiman, J., 2013. Complex Ⅱ deficiency—a case report and review of the literature. Am. J. Med. Genet. 161A, 285-294.

Jiang, X., Stockwell, B.R., Conrad, M., 2021. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266-282.

Karczewski, K.J., Francioli, L.C., Tiao, G., Cummings, B.B., Alfoldi, J., Wang, Q., Collins, R.L., Laricchia, K.M., Ganna, A., Birnbaum, D.P., 2020. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434-443.

Lightowlers, R.N., Taylor, R.W., Turnbull, D.M., 2015. Mutations causing mitochondrial disease: what is new and what challenges remain?. Science 349, 1494-1499.

Morava, E., van den Heuvel, L., Hol, F., de Vries, M.C., Hogeveen, M., Rodenburg, R.J., Smeitink, J.A., 2006. Mitochondrial disease criteria: diagnostic applications in children. Neurology 67, 1823-1826.

Nakamoto, C., Kawamura, M., Nakatsukasa, E., Natsume, R., Takao, K., Watanabe, M., Abe, M., Takeuchi, T., Sakimura, K., GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior. PLoS One e0229288.

Nenadic, I., Maitra, R., Scherpiet, S., Gaser, C., Schultz, C.C., Schachtzabel, C., Smesny, S., Reichenbach, J.R., Treutlein, J., Muhleisen, T.W., 2012. Glutamate receptor delta 1 (GRID1) genetic variation and brain structure in schizophrenia. J. Psychiatr. Res. 46, 1531-1539.

Nomoto, H., Ishikane, M., Nakamoto, T., Ohta, M., Morioka, S., Yamamoto, K., Kutsuna, S., Tezuka, S., Kunimatsu, J., Ohmagari, N., Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019. PloS One e0231966.

Osellame, L.D., Blacker, T.S., Duchen, M.R., 2012. Cellular and molecular mechanisms of mitochondrial function. Best Pract. Res. Clin. Endocrinol. Metabol. 26, 711-723.

Qamar, W., Khan, M.R., Arafah, A., 2017. Optimization of conditions to extract high quality DNA for PCR analysis from whole blood using SDS-proteinase K method. Saudi J. Biol. Sci. 24, 1465-1469.

Sakai, C., Yamaguchi, S., Sasaki, M., Miyamoto, Y., Matsushima, Y., Goto, Y., 2015. ECHS1 mutations cause combined respiratory chain deficiency resulting in Leigh syndrome. Hum. Mutat. 36, 232-239.

Sun, Y., Hu, G., Liu, H., Zhang, X., Huang, Z., Yan, H., Wang, L., Fan, Y., Gu, X., Yu, Y., 2017. Further delineation of the phenotype of truncating KMT2A mutations: the extended Wiedemann-Steiner syndrome. Am. J. Med. Genet. 173, 510-514.

Wei, X., Du, M., Li, D., Wen, S., Xie, J., Li, Y., Chen, A., Zhang, K., Xu, P., Jia, M., 2020. Mutations in FASTKD2 are associated with mitochondrial disease with multi-OXPHOS deficiency. Hum. Mutat. 41, 961-972.

Wortmann, S.B., Vaz, F.M., Gardeitchik, T., Vissers, L.E., Renkema, G.H., Schuurs-Hoeijmakers, J.H., Kulik, W., Lammens, M., Christin, C., Kluijtmans, L.A., 2012. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat. Genet. 44, 797-802.

Xie, Y., Lv, X., Ni, D., Liu, J., Hu, Y., Liu, Y., Liu, Y., Liu, R., Zhao, H., Lu, Z., 2019. HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage. Nat. Commun. 10, 4266.

Yamazaki, M., Araki, K., Shibata, A., Mishina, M., 1992. Molecular cloning of a cDNA encoding a novel member of the mouse glutamate receptor channel family. Biochem. Biophys. Res. Commun. 183, 886-892.

Yan, H.F., Zou, T., Tuo, Q.Z., Xu, S., Li, H., Belaidi, A.A., Lei, P., 2021. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 6, 49.

Ye, X., Wei, X., Liao, J., Chen, P., Li, X., Chen, Y., Yang, Y., Zhao, Q., Sun, H., Pan, L., Chen, G., He, X., Lyu, J., 2021. 4-hydroxyphenylpyruvate dioxygenase-like protein promotes pancreatic cancer cell progression and is associated with glutamine-mediated redox balance. Front. Oncol. 10, 617190.

Zhang, T., Hou, L., Chen, D.T., McMahon, F.J., Wang, J.C., Rice, J.P., 2018. Exome sequencing of a large family identifies potential candidate genes contributing risk to bipolar disorder. Gene 645, 119-123.

Relative Articles

Supplements(0)

Cited By

Proportional views